Context Capital Management’s Cerevel Therapeutics Holdings CERE Stock Holding History
Bought
Maintained
Sold
Other funds holding CERE
AG
Context Capital Management's CERE Position: Q4 2020 in Review
Context Capital Management sold out of Cerevel Therapeutics Holdings (CERE) in Q4 2020, closing a stake of 270,000 shares — an estimated $2.82M sold.
Context Capital Management first reported a position in CERE in Q3 2020 and held it in 1 quarter. The position peaked at $2.82M in Q3 2020. 58 funds tracked by Wall St. Rank hold CERE as of Q4 2020.
- Context Capital Management reported no remaining Cerevel Therapeutics Holdings position as of Q4 2020 after selling out during the quarter.
- Context Capital Management sold 270,000 Cerevel Therapeutics Holdings shares in Q4 2020, an estimated $2.82M.
- Context Capital Management first reported a position in Cerevel Therapeutics Holdings in Q3 2020 and held it in 1 quarter.
- Context Capital Management's Cerevel Therapeutics Holdings position peaked at $2.82M in Q3 2020.
- 58 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings as of Q4 2020.
Based on Context Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.